000126145 001__ 126145
000126145 005__ 20240228140810.0
000126145 0247_ $$2doi$$a10.1002/ijc.28974
000126145 0247_ $$2pmid$$apmid:24828787
000126145 0247_ $$2ISSN$$a0020-7136
000126145 0247_ $$2ISSN$$a1097-0215
000126145 037__ $$aDKFZ-2017-02260
000126145 041__ $$aeng
000126145 082__ $$a610
000126145 1001_ $$aBhattacharya, Nupur$$b0
000126145 245__ $$aLoss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6.
000126145 260__ $$aBognor Regis$$bWiley-Liss$$c2015
000126145 3367_ $$2DRIVER$$aarticle
000126145 3367_ $$2DataCite$$aOutput Types/Journal article
000126145 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1508401502_6998
000126145 3367_ $$2BibTeX$$aARTICLE
000126145 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000126145 3367_ $$00$$2EndNote$$aJournal Article
000126145 520__ $$aChronic lymphocytic leukemia (CLL) cells fail to enter apoptosis in vivo as opposed to their non-malignant B-lymphocyte counterparts. The ability of CLL cells to escape apoptosis is highly dependent on their microenvironment. Compared to non-malignant B cells, CLL cells are more responsive to complex stimuli that can be reproduced in vitro by the addition of cytokines. To understand the molecular mechanism of the environment-dependent anti-apoptotic signaling circuitry of CLL cells, we quantified the effect of the SDF-1, BAFF, APRIL, anti-IgM, interleukin-4 (IL4) and secreted CD40L (sCD40L) on the survival of in vitro cultured CLL cells and found IL4 and sCD40L to be most efficient in rescuing CLL cells from apoptosis. In quantitative dose-response experiments using cell survival as readout, the binding affinity of IL4 to its receptor was similar between malignant and non-malignant cells. However, the downstream signaling in terms of the amount of STAT6 and its degree of phosphorylation was highly stimulated in CLL cells. In contrast, the response to sCD40L showed a loss of cooperative binding in CLL cells but displayed a largely increased ligand binding affinity. Although a high-throughput microscopy analysis did not reveal a significant difference in the spatial CD40 receptor organization, the downstream signaling showed an enhanced activation of the NF-kB pathway in the malignant cells. Thus, we propose that the anti-apoptotic phenotype of CLL involves a sensitized response for IL4 dependent STAT6 phosphorylation, and an activation of NF-kB signaling due to an increased affinity of sCD40L to its receptor.
000126145 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000126145 588__ $$aDataset connected to CrossRef, PubMed,
000126145 650_7 $$2NLM Chemicals$$aIL4 protein, human
000126145 650_7 $$2NLM Chemicals$$aNF-kappa B
000126145 650_7 $$2NLM Chemicals$$aSTAT6 Transcription Factor
000126145 650_7 $$2NLM Chemicals$$aSTAT6 protein, human
000126145 650_7 $$0147205-72-9$$2NLM Chemicals$$aCD40 Ligand
000126145 650_7 $$0207137-56-2$$2NLM Chemicals$$aInterleukin-4
000126145 7001_ $$0P:(DE-HGF)0$$aReichenzeller, Michaela$$b1
000126145 7001_ $$0P:(DE-He78)0137d9152be648373d139f096eeebf71$$aCaudron-Herger, Maiwen$$b2$$udkfz
000126145 7001_ $$aHaebe, Sarah$$b3
000126145 7001_ $$0P:(DE-He78)5bf984e94f0a31773a103cd293e01f92$$aBrady, Nathan R$$b4$$udkfz
000126145 7001_ $$aDiener, Susanne$$b5
000126145 7001_ $$aNothing, Maria$$b6
000126145 7001_ $$aDöhner, Hartmut$$b7
000126145 7001_ $$aStilgenbauer, Stephan$$b8
000126145 7001_ $$0P:(DE-He78)94de5f7413279464b6e738d91dfae1eb$$aRippe, Karsten$$b9$$udkfz
000126145 7001_ $$0P:(DE-He78)833c06a995d272b78f3a20df3eba6e9e$$aMertens, Daniel$$b10$$eLast author$$udkfz
000126145 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.28974$$gVol. 136, no. 1, p. 65 - 73$$n1$$p65 - 73$$tInternational journal of cancer$$v136$$x0020-7136$$y2015
000126145 909CO $$ooai:inrepo02.dkfz.de:126145$$pVDB
000126145 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0137d9152be648373d139f096eeebf71$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000126145 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5bf984e94f0a31773a103cd293e01f92$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000126145 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)94de5f7413279464b6e738d91dfae1eb$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000126145 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)833c06a995d272b78f3a20df3eba6e9e$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000126145 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000126145 9141_ $$y2015
000126145 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000126145 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000126145 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000126145 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000126145 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2015
000126145 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000126145 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000126145 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000126145 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000126145 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000126145 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000126145 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2015
000126145 9201_ $$0I:(DE-He78)B170-20160331$$kB170$$lSystembiologie von Zelltod-Mechanismen$$x0
000126145 9201_ $$0I:(DE-He78)B066-20160331$$kB066$$lGenomorganisation und Funktion$$x1
000126145 9201_ $$0I:(DE-He78)B061-20160331$$kB061$$lMechanismen der Leukämogenese$$x2
000126145 980__ $$ajournal
000126145 980__ $$aVDB
000126145 980__ $$aI:(DE-He78)B170-20160331
000126145 980__ $$aI:(DE-He78)B066-20160331
000126145 980__ $$aI:(DE-He78)B061-20160331
000126145 980__ $$aUNRESTRICTED